Saad Kenderian
8Patents
2h-index
33Co-inventors
43Inventor score
Filing activity: Apr 7, 2015 → Nov 9, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9815901B2 | Treatment of cancer using a CD123 chimeric antigen receptor | Chemistry; Metallurgy | 80 | Active |
| US10357514B2 | Treatment of cancer using anti-CD19 Chimeric Antigen Receptor | Chemistry; Metallurgy | 7 | Active |
| US10568947B2 | Treatment of cancer using a CLL-1 chimeric antigen receptor | Chemistry; Metallurgy | 1 | Active |
| US12257286B2 | Methods and materials for treating cancer | Physics | 0 | Active |
| US10703819B2 | Treatment of cancer using a CD123 chimeric antigen receptor | Chemistry; Metallurgy | 0 | Active |
| US11591404B2 | Treatment of cancer using a CD123 chimeric antigen receptor | Chemistry; Metallurgy | 0 | Active |
| US12264189B2 | Methods and materials for treating cancer | Chemistry; Metallurgy | 0 | Active |
| US12139544B2 | EphA3 directed CAR-T cells for treatment of tumors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.